Todd Schonherz - 16 Jul 2024 Form 4 Insider Report for American Oncology Network, Inc. (AONC)

Role
Chief Executive Officer, Director
Signature
Stephen Spivey, attorney-in-fact
Issuer symbol
AONC
Transactions as of
16 Jul 2024
Net transactions value
$0
Form type
4
Filing time
18 Jul 2024, 16:38:41 UTC
Previous filing
30 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AONC Class A Common Stock Award $0 +300,000 +5618% $0.000000 305,340 16 Jul 2024 Direct F1
holding AONC Class B Common Stock 869,459 16 Jul 2024 Via Schonherz Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 300,000 shares of Class A Common Stock granted for service as Chief Executive Officer of American Oncology Network, Inc. 195,000 shares will vest on a time-based vesting schedule over four years and 105,000 shares will vest based on a performance-based vesting schedule. Both vesting schedules will be accelerated upon a change in control.